Hybrid Close-Loop Systems Versus Predictive Low-Glucose Suspend and Sensor-Augmented Pump Therapy in Patients With Type 1 Diabetes: A Single-Center Cohort Study.
Lunati ME, Morpurgo PS, Rossi A, Gandolfi A, Cogliati I, Bolla AM, Plebani L, Vallone L, Montefusco L, Pastore I, Cimino V, Argenti S, Volpi G, Zuccotti GV, Fiorina P.
Lunati ME, et al. Among authors: cogliati i.
Front Endocrinol (Lausanne). 2022 Apr 14;13:816599. doi: 10.3389/fendo.2022.816599. eCollection 2022.
Front Endocrinol (Lausanne). 2022.
PMID: 35498423
Free PMC article.